ACOD1 and cancer: In 2023, Wang et al., applied metabolic gene knockout on CAR-iMACS to neutralise the Aconitate Decarboxylase 1 (ACOD1) gene and obtained M1 polarized CAR-iMACS with a more potent phagocytic and cytotoxic activity against cancer cells.